These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31529493)

  • 41. Immunosuppressive and immunomodulating therapy for atopic dermatitis in pregnancy: an appraisal of the literature.
    Drljevic-Nielsen A; Heilskov S; Deleuran MS; Vestergaard C
    Ital J Dermatol Venerol; 2024 Feb; 159(1):23-33. PubMed ID: 38226937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.
    Sidbury R; Tom WL; Bergman JN; Cooper KD; Silverman RA; Berger TG; Chamlin SL; Cohen DE; Cordoro KM; Davis DM; Feldman SR; Hanifin JM; Krol A; Margolis DJ; Paller AS; Schwarzenberger K; Simpson EL; Williams HC; Elmets CA; Block J; Harrod CG; Smith Begolka W; Eichenfield LF
    J Am Acad Dermatol; 2014 Dec; 71(6):1218-33. PubMed ID: 25264237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic therapeutic options for severe atopic dermatitis.
    BuBmann C; Bieber T; Novak N
    J Dtsch Dermatol Ges; 2009 Mar; 7(3):205-19. PubMed ID: 18759739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic Agents for Severe Atopic Dermatitis in Children.
    Notaro ER; Sidbury R
    Paediatr Drugs; 2015 Dec; 17(6):449-57. PubMed ID: 26547214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis.
    Dias-Polak D; Bergman R; Avitan-Hersh E
    J Dermatolog Treat; 2019 Feb; 30(1):49-51. PubMed ID: 29683760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
    Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T
    J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
    Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
    J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment options for atopic dermatitis.
    Buys LM
    Am Fam Physician; 2007 Feb; 75(4):523-8. PubMed ID: 17323714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical treatment for atopic dermatitis in the 21st century.
    Johnson SM; Kincannon JM; Dudney DL;
    J Ark Med Soc; 2004 Sep; 101(3):86-90. PubMed ID: 15384500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
    Simpson EL; Bruin-Weller M; Flohr C; Ardern-Jones MR; Barbarot S; Deleuran M; Bieber T; Vestergaard C; Brown SJ; Cork MJ; Drucker AM; Eichenfield LF; Foelster-Holst R; Guttman-Yassky E; Nosbaum A; Reynolds NJ; Silverberg JI; Schmitt J; Seyger MMB; Spuls PI; Stalder JF; Su JC; Takaoka R; Traidl-Hoffmann C; Thyssen JP; van der Schaft J; Wollenberg A; Irvine AD; Paller AS
    J Am Acad Dermatol; 2017 Oct; 77(4):623-633. PubMed ID: 28803668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA).
    Argenziano G; Cusano F; Corazza M; Amato S; Amerio P; Naldi L; Patruno C; Pigatto PD; Quaglino P; Gisondi P; Chiricozzi A; Tonon F; Stingeni L; Calzavara-Pinton P; Wollenberg A; Kinberger M; Arents BW; Aszodi N; Avila Valle GL; Barbarot S; Bieber T; Brough HA; Christen-Zäch S; Deleuran M; Dittmann M; Dressler C; Fink-Wagner AH; Fosse N; Gáspár K; Gerbens LA; Gieler U; Girolomoni G; Gregoriou S; Mortz CG; Nast A; Nygaard U; Redding M; Rehbinder EM; Ring J; Rossi M; Serra-Baldrich E; Simon D; Szalai ZZ; Szepietowski JC; Torrelo A; Werfel T; Flohr C
    Ital J Dermatol Venerol; 2024 Jun; 159(3):223-250. PubMed ID: 38727633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].
    Gliński W; Kruszewski J; Silny W; Kurzawa R; Czarnecka-Operacz M; Baran E; Szepietowski J;
    Pol Merkur Lekarski; 2004; 17 Suppl 3():3-15. PubMed ID: 15688665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists.
    Taylor K; Swan DJ; Affleck A; Flohr C; Reynolds NJ;
    Br J Dermatol; 2017 Jun; 176(6):1617-1623. PubMed ID: 27943248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
    Meggitt SJ; Gray JC; Reynolds NJ
    Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atopic dermatitis: recent insight on pathogenesis and novel therapeutic target.
    D'Auria E; Banderali G; Barberi S; Gualandri L; Pietra B; Riva E; Cerri A
    Asian Pac J Allergy Immunol; 2016 Jun; 34(2):98-108. PubMed ID: 27007830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term Treatment of Atopic Dermatitis.
    Prezzano JC; Beck LA
    Dermatol Clin; 2017 Jul; 35(3):335-349. PubMed ID: 28577803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chinese herbal medicine granules (PTQX) for children with moderate to severe atopic eczema: study protocol for a randomised controlled trial.
    Gu SX; Zhang AL; Coyle ME; Mo X; Lenon GB; Cranswick NE; Chen D; Xue CC
    Trials; 2015 Jul; 16():294. PubMed ID: 26149448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Azathioprine for atopic dermatitis.
    Meggitt SJ; Reynolds NJ
    Clin Exp Dermatol; 2001 Jul; 26(5):369-75. PubMed ID: 11488818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging Treatment Options in Atopic Dermatitis: Topical Therapies.
    Nygaard U; Deleuran M; Vestergaard C
    Dermatology; 2017; 233(5):333-343. PubMed ID: 29216643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.